What was NewGen BioPharma’s price range in the past 12 months?
NewGen BioPharma lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is NewGen BioPharma’s market cap?
NewGen BioPharma’s market cap is $23.
When is NewGen BioPharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is NewGen BioPharma overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does NewGen BioPharma pay dividends?
NewGen BioPharma does not currently pay dividends.
What is NewGen BioPharma’s EPS estimate?
NewGen BioPharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NewGen BioPharma have?
NewGen BioPharma has 22,600,000 shares outstanding.
Which hedge fund is a major shareholder of NewGen BioPharma?
Currently, no hedge funds are holding shares in NEWG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NewGen BioPharma
Greenwind Holdings Inc. is a development-stage enterprise primarily focused on identifying and acquiring various investment opportunities. Established in 2010, the company was formerly known as NewGen BioPharma Corp. until its rebranding to Greenwind Holdings Inc. in April 2017. Its headquarters are located in Seattle, Washington.